NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
| NUTX Stock | USD 33.32 1.27 3.67% |
Slightly above 61% of Nutex Health's investor base is looking to short. The analysis of overall sentiment of trading Nutex Health stock suggests that many investors are alarmed at this time. Nutex Health's investing sentiment can be driven by a variety of factors including economic data, Nutex Health's earnings reports, geopolitical events, and overall market trends.
Nutex |
Nutex Health Inc. , a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will be presenting at the industrys largest healthcare investment symposium the 43rd Annual J.P. Morgan Healthcare Conference. This event will take place from January 13th to 16th in San Francisco, California.
Read at finance.yahoo.com
 |
Nutex Health Fundamental Analysis
We analyze Nutex Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutex Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutex Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Nutex Health is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Nutex Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nutex Health stock to make a market-neutral strategy. Peer analysis of Nutex Health could also be used in its relative valuation, which is a method of valuing Nutex Health by comparing valuation metrics with similar companies.
Peers
Nutex Health Related Equities
| MGRX | Mangoceuticals, Common | 2.64 | ||||
| HSTM | HealthStream | 1.16 | ||||
| PRVA | Privia Health | 0.25 | ||||
| EVH | Evolent Health | 0.33 | ||||
| NRC | National Research | 1.75 | ||||
| EUDA | EUDA Health | 2.15 | ||||
| BFRG | Bullfrog | 4.82 | ||||
| BEAT | Heartbeam | 4.85 | ||||
| STRM | Streamline Health | 4.91 | ||||
| FOXO | FOXO Technologies | 6.45 | ||||
| HCTI | Healthcare Triangle | 27.65 |
Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.